John E Bishop
CIK 1308911 · See Remarks · last filed 2026-05-22
John E Bishop is a corporate insider who has filed 132 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider sold $14.5K of ARDX on May 22, 2026. Across all open-market trades the lifetime net is −$6.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.92M
4
132
-$6.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | See Remarks | 336,845 | $5.69 | $1.92M | -$33.0K | 3 | 2026-05-22 |
| LYRA | Chief Technology Officer | — | $0.70 | — | $0 | 2 | 2024-02-01 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | SVP, Chief Technology Officer | 0 | $20.01 | $0 | $0 | 3 | 2022-10-14 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Senior VP, Pharmaceutical Scie | 157,640 | — | — | -$6.40M | 124 | 2016-05-23 |
Recent Filings
132 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | ARDX | Sell (S) | −2,306 | -$14.5K | EDGAR |
| 2026-02-23 | ARDX | Sell (S) | −3,179 | -$18.6K | EDGAR |
| 2026-01-26 | ARDX | Grant (A) | +124,330 | $0 | EDGAR |
| 2024-02-01 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2023-02-28 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2022-10-14 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Mixed | −47,950 | $0 | EDGAR |
| 2022-03-02 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +25,950 | $0 | EDGAR |
| 2021-06-15 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +22,000 | $0 | EDGAR |
| 2016-05-23 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −784 | -$8.0K | EDGAR |
| 2016-04-19 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Mixed | −9,049 | -$87.3K | EDGAR |